Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Katzenstein

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup studyHoward M Katzenstein, Mark D Krailo, Marcio H Malogolowkin, et al.
Pediatric Blood & Cancer|November 6, 2024
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531Julie Voeller, Howard M Katzenstein, Arlene Naranjo, et al.
The Lancet. Oncology|April 13, 2019
Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trialHoward M Katzenstein, Max R Langham, Marcio H Malogolowkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2017
Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology GroupAllison F O'Neill, Alexander J Towbin, Mark D Krailo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.
Journal of Pediatric Surgery|July 9, 2022
Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731Sanjeev A Vasudevan, Rebecka L Meyers, Milton J Finegold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2021
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study CommitteeAngela Trobaugh-Lotrario, Howard M Katzenstein, Sarangarajan Ranganathan, et al.
Pediatric Blood & Cancer|April 19, 2023
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study CommitteePatrick A Thompson, Marcio H Malogolowkin, Wayne L Furman, et al.
Cancer|November 11, 2021
Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group studyHoward M Katzenstein, Marcio H Malogolowkin, Mark D Krailo, et al.
Annals of Surgery|September 25, 2025
Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III TrialZachary J Kastenberg, Sanjeev A Vasudevan, Lucy Dolmadjian, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup studyHoward M Katzenstein, Mark D Krailo, Marcio H Malogolowkin, et al.
Pediatric Blood & Cancer|November 6, 2024
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531Julie Voeller, Howard M Katzenstein, Arlene Naranjo, et al.
The Lancet. Oncology|April 13, 2019
Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trialHoward M Katzenstein, Max R Langham, Marcio H Malogolowkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2017
Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology GroupAllison F O'Neill, Alexander J Towbin, Mark D Krailo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.
Journal of Pediatric Surgery|July 9, 2022
Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731Sanjeev A Vasudevan, Rebecka L Meyers, Milton J Finegold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2021
Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study CommitteeAngela Trobaugh-Lotrario, Howard M Katzenstein, Sarangarajan Ranganathan, et al.
Pediatric Blood & Cancer|April 19, 2023
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study CommitteePatrick A Thompson, Marcio H Malogolowkin, Wayne L Furman, et al.
Cancer|November 11, 2021
Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group studyHoward M Katzenstein, Marcio H Malogolowkin, Mark D Krailo, et al.
Annals of Surgery|September 25, 2025
Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III TrialZachary J Kastenberg, Sanjeev A Vasudevan, Lucy Dolmadjian, et al.
Pageof 12